These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9871496)

  • 1. Is there a correlation between taurine levels and xenobiotic-induced perturbations in protein synthesis?: a study with tetracycline in rats.
    Waterfield CJ; Asker DS; Patel S; Timbrell JA
    Amino Acids; 1998; 15(1-2):161-77. PubMed ID: 9871496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does urinary taurine reflect changes in protein metabolism? A study with cycloheximide in rats.
    Waterfield CJ; Asker DS; Timbrell JA
    Biomarkers; 1996; 1(2):107-14. PubMed ID: 23888921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride-treated rats.
    Waterfield CJ; Turton JA; Scales MD; Timbrell JA
    Arch Toxicol; 1991; 65(7):548-55. PubMed ID: 1685880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of various non-hepatotoxic compounds on urinary and liver taurine levels in rats.
    Waterfield CJ; Turton JA; Scales MD; Timbrell JA
    Arch Toxicol; 1993; 67(8):538-46. PubMed ID: 8285852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemical effects of clenbuterol: with particular reference to taurine and muscle damage.
    Waterfield CJ; Jairath M; Asker DS; Timbrell JA
    Eur J Pharmacol; 1995 Jul; 293(2):141-9. PubMed ID: 7589228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats.
    Waterfield CJ; Turton JA; Scales MD; Timbrell JA
    Arch Toxicol; 1993; 67(4):244-54. PubMed ID: 8517780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment with beta-agonists on tissue and urinary taurine levels in rats. Mechanism and implications for protection.
    Waterfield CJ; Carvalho F; Timbrell JA
    Adv Exp Med Biol; 1996; 403():233-45. PubMed ID: 8915360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in urinary taurine and hypotaurine excretion after two-thirds hepatectomy in the rat.
    Brand HS; Jörning GG; Chamuleau RA
    Amino Acids; 1998; 15(4):373-83. PubMed ID: 9891761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between urinary and liver taurine levels and between pre-dose urinary taurine and liver damage.
    Waterfield CJ; Turton JA; Scales MD; Timbrell JA
    Toxicology; 1993 Jan; 77(1-2):1-5. PubMed ID: 8442006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary taurine as a non-invasive marker of aflatoxin B1-induced hepatotoxicity: success and failure.
    Maxuitenko YY; North WG; Roebuck BD
    Toxicology; 1997 Mar; 118(2-3):159-69. PubMed ID: 9129170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro.
    Timbrell JA; Waterfield CJ
    Adv Exp Med Biol; 1996; 403():125-34. PubMed ID: 8915350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the muscle toxicant 2,3,5,6-tetramethyl p-phenylenediamine: effects on various biomarkers including urinary creatine and taurine.
    Draper RP; Waterfield CJ; York MJ; Timbrell JA
    Arch Toxicol; 1994; 69(2):111-7. PubMed ID: 7717859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxin-induced hypertaurinuria: a proton NMR study.
    Sanins SM; Nicholson JK; Elcombe C; Timbrell JA
    Arch Toxicol; 1990; 64(5):407-11. PubMed ID: 2169721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of ethanol-induced hepatic steatosis and lipid peroxidation by taurine: a study in rats.
    Kerai MD; Waterfield CJ; Kenyon SH; Asker DS; Timbrell JA
    Alcohol Alcohol; 1999; 34(4):529-41. PubMed ID: 10456581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rat vascular smooth muscle cell proliferation by taurine and taurine analogues.
    Zhang X; Tenner TE; Lombardini JB
    Biochem Pharmacol; 1999 Jun; 57(11):1331-9. PubMed ID: 10230777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of mammalian protein synthesis in vivo. Stimulated protein synthesis in liver in vivo after cycloheximide treatment.
    Ch'ih JJ; Procyk R; Devlin TM
    Biochem J; 1977 Mar; 162(3):501-7. PubMed ID: 869902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine: protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats.
    Kerai MD; Waterfield CJ; Kenyon SH; Asker DS; Timbrell JA
    Amino Acids; 1998; 15(1-2):53-76. PubMed ID: 9871487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the beta 2-agonist drug clenbuterol on taurine levels in heart and other tissues in the rat.
    Doheny MH; Waterfield CJ; Timbrell JA
    Amino Acids; 1998; 15(1-2):13-25. PubMed ID: 9871484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of liver taurine in rats by beta-alanine treatment increases carbon tetrachloride toxicity.
    Waterfield CJ; Turton JA; Scales MD; Timbrell JA
    Toxicology; 1993 Jan; 77(1-2):7-20. PubMed ID: 8442020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet.
    Yokogoshi H; Mochizuki H; Nanami K; Hida Y; Miyachi F; Oda H
    J Nutr; 1999 Sep; 129(9):1705-12. PubMed ID: 10460208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.